Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy

Nonviral vectors for gene delivery

Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

Lai, S. K., Wang, Y.-Y., & Hanes, J. S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,863

Barrier properties of mucus

Cone, R. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459

Degradable poly (β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA

Lynn, D. M., & Langer, R. (2000) · Journal of the American Chemical Society · doi:10.1021/ja0015388 · Cited by 924

PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles

Mishra, S., Webster, P. C., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 740

Cell number and cell characteristics of the normal human lung.

Crapo, J. D., Barry, B. E., Gehr, P., Bachofen, M., & Weibel, E. R. (1982) · PubMed · doi:10.1164/arrd.1982.125.6.740 · Cited by 730

Immune responses to gene therapy vectors: influence on vector function and effector mechanisms

Bessis, N., Garcia-Cozar, F. J., & Boissier, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302364 · Cited by 653

New Drugs for Rheumatoid Arthritis

Olsen, N. J., & Stein, C. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032906 · Cited by 632

A combinatorial polymer library approach yields insight into nonviral gene delivery

Green, J. J., Langer, R., & Anderson, D. G. (2008) · Accounts of Chemical Research · doi:10.1021/ar7002336 · Cited by 579

Nanoparticle diffusion in respiratory mucus from humans without lung disease

Schuster, B. S., Suk, J. S., Woodworth, G. F., & Hanes, J. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.064 · Cited by 478

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523

The current state and future directions of RNAi-based therapeutics

Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443

Drug delivery systems for RNA therapeutics

Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645

Physiology and pathophysiology of human airway mucus

Hill, D. B., Button, B. M., Rubinstein, M., & Boucher, R. C. (2022) · Physiological Reviews · doi:10.1152/physrev.00004.2021 · Cited by 406

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

Brenner, J. S., Pan, D. C., Myerson, J. W., Marcos-Contreras, O. A., Villa, C. H., Patel, P., Hekierski, H., Chatterjee, S., Tao, J.-Q., Parhiz, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05079-7 · Cited by 363

Polymer–Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs

Kaczmarek, J. C., Patel, A. K., Kauffman, K. J., Fenton, O. S., Webber, M. J., Heartlein, M. W., DeRosa, F., & Anderson, D. G. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201608450 · Cited by 337

Low ambient humidity impairs barrier function and innate resistance against influenza infection

Kudo, E., Song, E., Yockey, L. J., Rakib, T., Wong, P., Homer, R., & Iwasaki, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902840116 · Cited by 336

The role of mucus on drug transport and its potential to affect therapeutic outcomes

Murgia, X., Loretz, B., Hartwig, O., Hittinger, M., & Lehr, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.009 · Cited by 341

Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation

Schneider, C. S., Xu, Q., Boylan, N. J., Chisholm, J., Tang, B. C., Schuster, B. S., Henning, A., Ensign, L. M., Lee, E. N., Adstamongkonkul, P., et al. (2017) · Science Advances · doi:10.1126/sciadv.1601556 · Cited by 321

PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy

Osman, G., Rodriguez, J., Chan, S. Y., Chisholm, J., Duncan, G. A., Kim, N., Tatler, A. L., Shakesheff, K. M., Hanes, J. S., Suk, J. S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.001 · Cited by 209

Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities

Karlsson, J. E., Rhodes, K. R., Green, J. J., & Tzeng, S. Y. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1796628 · Cited by 196

Poly(β‐Amino Esters): Synthesis, Formulations, and Their Biomedical Applications

Liu, Y., Li, Y., Keskin, D., & Shi, L. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801359 · Cited by 192

The Mucus Barrier to Inhaled Gene Therapy

Duncan, G. A., Jung, J., Hanes, J. S., & Suk, J. S. (2016) · Molecular Therapy · doi:10.1038/mt.2016.182 · Cited by 195

CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis

Lopes‐Pacheco, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00275 · Cited by 205

Potential applications and human biosafety of nanomaterials used in nanomedicine

Su, H., Wang, Y., Gu, Y., Bowman, L. L., Zhao, J., & Ding, M. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3476 · Cited by 179

Selective permeability of mucus barriers

Witten, J. J., Samad, T. S., & Ribbeck, K. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.03.010 · Cited by 176

Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson’s Disease Model

Mead, B. P., Kim, N., Miller, G. W., Hodges, D., Mastorakos, P., Klibanov, A. L., Mandell, J. W., Hirsh, J., Suk, J. S., Hanes, J., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b00616 · Cited by 151

Engineering the Mucus Barrier

Carlson, T. L., Lock, J. Y., & Carrier, R. L. (2018) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121156 · Cited by 165

Biodegradable Polymers for Gene Delivery

Thomas, T., Tajmir‐Riahi, H., & Pillai, C. K. S. (2019) · Molecules · doi:10.3390/molecules24203744 · Cited by 163

Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes

Morales, J. O., Fathe, K., Brunaugh, A. D., Ferrati, S., Li, S., Montenegro-Nicolini, M., Mousavikhamene, Z., McConville, J. T., Prausnitz, M. R., & Smyth, H. D. C. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0054-z · Cited by 159

New and emerging targeted therapies for cystic fibrosis

Quon, B. S., & Rowe, S. M. (2016) · BMJ · doi:10.1136/bmj.i859 · Cited by 159

The particle in the spider's web: transport through biological hydrogels

Witten, J. J., & Ribbeck, K. (2017) · Nanoscale · doi:10.1039/c6nr09736g · Cited by 154

PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy

Kesharwani, P., Kumar, V., Goh, K. W., Gupta, G., Alsayari, A., Wahab, S., & Sahebkar, A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02410-x · Cited by 132

Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines

Jorritsma, S. H. T., Gowans, E. J., Grubor‐Bauk, B., & Wijesundara, D. K. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.09.062 · Cited by 132

Patented therapeutic drug delivery strategies for targeting pulmonary diseases

Thakur, A. K., Chellappan, D. K., Dua, K., Mehta, M., Satija, S., & Singh, I. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1741547 · Cited by 132

Protein nanocages that penetrate airway mucus and tumor tissue

Huang, X., Chisholm, J., Zhuang, J., Xiao, Y., Duncan, G., Chen, X., Suk, J. S., & Hanes, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705407114 · Cited by 131

Self-assembled peptide–poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis

Guan, S., Munder, A., Hedtfeld, S., Braubach, P., Glage, S., Zhang, L., Lienenklaus, S., Schultze, A., Hasenpusch, G., Garrels, W., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0358-x · Cited by 130

Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases

Deng, Z., Kalin, G. T., Shi, D., & Kalinichenko, V. V. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0306tr · Cited by 134

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine

Pranke, I. M., Golec, A., Hinzpeter, A., Edelman, A., & Sermet‐Gaudelus, I. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00121 · Cited by 127

An Inhalable Hybrid Biomimetic Nanoplatform for Sequential Drug Release and Remodeling Lung Immune Homeostasis in Acute Lung Injury Treatment

Liu, C., Xi, L. F., Liu, Y., Mak, J., Mao, S., Wang, Z., & Zheng, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c02075 · Cited by 119

Barriers to inhaled gene therapy of obstructive lung diseases: A review

Kim, N., Duncan, G. A., Hanes, J. S., & Suk, J. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.031 · Cited by 122

Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches

Wang, W., Huang, Z., Huang, Y., Zhang, X., Huang, J., Cui, Y., Xiao, Y., Ma, C., Fu, F., Wang, W., et al. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114309 · Cited by 121

Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia

Krishnamurthy, S., Wohlford-Lenane, C., KANDIMALLA, S., Sartre, G., Meyerholz, D. K., Théberge, V., Hallée, S., Duperré, A.-M., Del’Guidice, T., Lepetit-Stoffaes, J.-P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12922-y · Cited by 116

Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier

Watchorn, J., Clasky, A. J., Prakash, G., Johnston, I. A. E., Chen, P., & Gu, F. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00047 · Cited by 119

Gel-forming mucin interactome drives mucus viscoelasticity

Demouveaux, B., Gouyer, V., Gottrand, F., Narita, T., & Desseyn, J. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.12.005 · Cited by 121

Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung

Chen, D., Liu, J., Wu, J., & Suk, J. S. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1854222 · Cited by 115

Chemical Design of Both a Glutathione-Sensitive Dimeric Drug Guest and a Glucose-Derived Nanocarrier Host to Achieve Enhanced Osteosarcoma Lung Metastatic Anticancer Selectivity

Su, L., Li, R., Khan, S. A., Clanton, R., Zhang, F., Lin, Y., Song, Y. H., Wang, H., Fan, J., Hernandez, S., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11462 · Cited by 108

Recent advances in nanoparticulate RNA delivery systems

Witten, J. J., Hu, Y., Langer, R., & Anderson, D. G. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307798120 · Cited by 113

Poly(β-amino ester)-based gene delivery systems: From discovery to therapeutic applications

Cordeiro, R. A., Serra, A. C., Coelho, J. F. J., & Faneca, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.024 · Cited by 107

Organ-on-a-chip technology for nanoparticle research

Kang, S., Park, S. E., & Huh, D. (2021) · Nano Convergence · doi:10.1186/s40580-021-00270-x · Cited by 101

Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery

Wang, H., Lu, Q., Zhang, X., Guan, J., & Mao, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.061 · Cited by 90

Polyamine–DNA interactions and development of gene delivery vehicles

Thomas, T., Tajmir‐Riahi, H. A., & Thomas, T. (2016) · Amino Acids · doi:10.1007/s00726-016-2246-8 · Cited by 84

Hypoxia-tropic Protein Nanocages for Modulation of Tumor- and Chemotherapy-Associated Hypoxia

Huang, X., Zhuang, J., Chung, S. W., Huang, B., Halpert, G., Negrón, K., Sun, X., Yang, J., Oh, Y., Hwang, P. M., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b05399 · Cited by 84

Developing inhaled protein therapeutics for lung diseases

Matthews, A. A., Ee, P. L. R., & Ge, R. (2020) · Molecular Biomedicine · doi:10.1186/s43556-020-00014-z · Cited by 82

Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics

Schneider, C. S., Bhargav, A. G., Perez, J. G., Wadajkar, A. S., Winkles, J. A., Woodworth, G. F., & Kim, A. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.048 · Cited by 85

Continuous Production of Discrete Plasmid DNA‐Polycation Nanoparticles Using Flash Nanocomplexation

Santos, J. L., Ren, Y., Vandermark, J., Archang, M. M., Williford, J., Liu, H., Lee, J., Wang, T., & Mao, H. (2016) · Small · doi:10.1002/smll.201601425 · Cited by 80

Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges

Ding, L., Tang, S., Wyatt, T. A., Knoell, D. L., & Oupický, D. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.005 · Cited by 79

Enhanced uptake in 2D- and 3D- lung cancer cell models of redox responsive PEGylated nanoparticles with sensitivity to reducing extra- and intracellular environments

Conte, C., Mastrotto, F., Taresco, V., Tchoryk, A., Quaglia, F., Stolnik, S., & Alexander, C. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.011 · Cited by 75

Molecular and cellular cues governing nanomaterial–mucosae interactions: from nanomedicine to nanotoxicology

das Neves, J., Arzi, R. S., & Sosnik, A. (2020) · Chemical Society Reviews · doi:10.1039/c8cs00948a · Cited by 74

New perspectives in nanotherapeutics for chronic respiratory diseases

da Silva, A. L., Cruz, F. F., Rocco, P. R. M., & Morales, M. M. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0319-x · Cited by 73

Proteomic analysis of intracellular protein corona of nanoparticles elucidates nano-trafficking network and nano-bio interactions

Qin, M., Zhang, J., Li, M., Yang, D., Liu, D., Song, S., Fu, J., Zhang, H., Dai, W., Wang, X., et al. (2020) · Theranostics · doi:10.7150/thno.38900 · Cited by 71

Poly-beta-amino-esters nano-vehicles based drug delivery system for cartilage

Perni, S., & Prokopovich, P. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.10.001 · Cited by 69

Oral Delivery of siRNA Using Fluorinated, Small‐Sized Nanocapsules toward Anti‐Inflammation Treatment

Wei, Y., Li, X., Lin, J., Zhou, Y., Yang, J., Hou, M., Wu, F., Yan, J., Ge, C., Hu, D., et al. (2022) · Advanced Materials · doi:10.1002/adma.202206821 · Cited by 65

Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery

Newby, J., Seim, I., Lysy, M., Ling, Y., Huckaby, J. T., Lai, S. K., & Forest, M. G. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.002 · Cited by 65

Delivering on the promise of gene editing for cystic fibrosis

Hodges, C. A., & Conlon, R. A. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.11.005 · Cited by 63

Delivery technologies for in utero gene therapy

Palanki, R., Peranteau, W. H., & Mitchell, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.11.002 · Cited by 64

Pro‐Peptide‐Reinforced, Mucus‐Penetrating Pulmonary siRNA Delivery Mitigates Cytokine Storm in Pneumonia

Yang, J., Duan, S., Ye, H., Ge, C., Piao, C., Chen, Y., Lee, M., & Yin, L. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008960 · Cited by 62

Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol

Neary, M. T., Mulder, L. M., Kowalski, P. S., MacLoughlin, R. J., Crean, A. M., & Ryan, K. B. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.012 · Cited by 63

Continuous microfluidic assembly of biodegradable poly(beta‐amino ester)/DNA nanoparticles for enhanced gene delivery

Wilson, D. R., Mosenia, A., Suprenant, M. P., Upadhya, R., Routkevitch, D., Meyer, R. A., Quiñones‐Hinojosa, A., & Green, J. J. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36033 · Cited by 62

Polymer–Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs

Kaczmarek, J. C., Patel, A. K., Kauffman, K. J., Fenton, O. S., Webber, M. J., Heartlein, M. W., DeRosa, F., & Anderson, D. G. (2016) · Angewandte Chemie · doi:10.1002/ange.201608450 · Cited by 60

An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy

Duncan, G. A., Kim, N., Colon-Cortes, Y., Rodriguez, J., Mazur, M., Birket, S. E., Rowe, S. M., West, N. E., Livraghi-Butrico, A., Boucher, R. C., et al. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.03.006 · Cited by 62

Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors

Mastorakos, P., Zhang, C., Song, E., Kim, Y., Park, H. W., Berry, S., Choi, W. K., Hanes, J. S., & Suk, J. S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.009 · Cited by 61

Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non–Muscle-Invasive Bladder Cancer

Kates, M. R., Date, A. A., Yoshida, T., Afzal, U., Kanvinde, P. P., Babu, T., Sopko, N. A., Matsui, H., Hahn, N. M., McConkey, D. J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1082 · Cited by 59

Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy

Zhu, D., Shen, H., Tan, S., Hu, Z., Wang, L., Yu, L., Tian, X., Ding, W., Ren, C., Gao, C., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.019 · Cited by 60

Novel Perspectives towards RNA-Based Nano-Theranostic Approaches for Cancer Management

Arshad, R., Fatima, I., Sargazi, S., Rahdar, A., Karamzadeh-Jahromi, M., Pandey, S., Diez-Pascual, A. M., & Bilal, M. (2021) · Nanomaterials · doi:10.3390/nano11123330 · Cited by 59

Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines

Guevara, M. L., Persano, S., & Persano, F. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190619150221 · Cited by 57

Inhaled immunoantimicrobials for the treatment of chronic obstructive pulmonary disease

Zhu, J., Li, X., Zhou, Y., Ge, C., Li, X., Hou, M., Wei, Y., Chen, Y., Leong, K. W., & Yin, L. (2024) · Science Advances · doi:10.1126/sciadv.abd7904 · Cited by 54

Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain

Mastorakos, P., Song, E., Zhang, C., Berry, S., Park, H. W., Kim, Y., Park, J., Lee, S., Suk, J. S., & Hanes, J. S. (2015) · Small · doi:10.1002/smll.201502554 · Cited by 53

Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth

Hoang, T., Zierden, H. C., Date, A. A., Ortiz, J., Gumber, S., Anders, N. M., He, P., Segars, J. H., Hanes, J. S., Mahendroo, M., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.046 · Cited by 53

The potential for targeted rewriting of epigenetic marks in COPD as a new therapeutic approach

Wu, D., Song, J., Bartel, S., Krauss‐Etschmann, S., Rots, M. G., & Hylkema, M. N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.007 · Cited by 50

Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano–bio interactions

Zhang, M., Lu, H., Xie, L., Liu, X., Cun, D., & Yang, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115144 · Cited by 50

Spatiotemporal Delivery of pBMP2 and pVEGF by a Core–Sheath Structured Fiber‐Hydrogel Gene‐Activated Matrix Loaded with Peptide‐Modified Nanoparticles for Critical‐Sized Bone Defect Repair

He, S., Fang, J., Zhong, C., Wang, M., & Ren, F. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201096 · Cited by 47

Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations

Majumder, J., & Minko, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071063 · Cited by 48

Gene Editing and Genetic Lung Disease. Basic Research Meets Therapeutic Application

Alapati, D., & Morrisey, E. E. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0301ps · Cited by 47

Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma

da Silva, A. L., Oliveira, G. P., Kim, N., Cruz, F. F., Kitoko, J. Z., Blanco, N. G., Martini, S. V., Hanes, J. S., Rocco, P. R. M., Suk, J. S., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay7973 · Cited by 46

Biomaterial-based nanoreactors, an alternative for enzyme delivery

Koyani, R. D., Pérez‐Robles, J., Cadena-Nava, R. D., & Vázquez-Duhalt, R. (2017) · Nanotechnology Reviews · doi:10.1515/ntrev-2016-0071 · Cited by 45

Poly (β‐amino esters) based potential drug delivery and targeting polymer; an overview and perspectives (review)

Iqbal, S., Qu, Y., Dong, Z., Zhao, J., Khan, A. R., Rehman, S., & Zhao, Z. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.110097 · Cited by 46

Advances in nanotechnology and asthma

Wang, L., Feng, M., Li, Q., Qiu, C., & Chen, R. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.04.62 · Cited by 45

Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics

Artzy‐Schnirman, A., Raviv, S. A., Doppelt‐Flikshtain, O., Shklover, J., Korin, N., Gross, A., Mizrahi, B., Schroeder, A., & Sznitman, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113901 · Cited by 45

Lessons learned from lung and liver in-vivo gene therapy: implications for the future

van Haasteren, J., Hyde, S. C., & Gill, D. R. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1506761 · Cited by 43

In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Ĉerenkov imaging

Black, K. C. L., Ibricevic, A., Gunsten, S. P., Flores, J. A., Gustafson, T. P., Raymond, J. E., Samarajeewa, S., Shrestha, R., Felder, S. E., Cai, T., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.040 · Cited by 39

Encapsulation and Ultrasound-Triggered Release of G-Quadruplex DNA in Multilayer Hydrogel Microcapsules

Alford, A., Tucker, B. A., Kozlovskaya, V., Chen, J., Gupta, N., Caviedes, R., Gearhart, J., Graves, D. E., & Kharlampieva, E. (2018) · Polymers · doi:10.3390/polym10121342 · Cited by 39

Genetic therapies for cystic fibrosis lung disease

Hart, S. L., & Harrison, P. T. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.10.006 · Cited by 40

Mucopenetrating lipoplexes modified with PEG and hyaluronic acid for CD44-targeted local siRNA delivery to the lungs

Almeida, A. P. B., Damaceno, G. B. R., Carneiro, A. F., Bohr, A., Gonçalves, H. R., Valadares, M. C., Nascimento, T. L., & Lima, E. M. (2019) · Journal of Biomaterials Applications · doi:10.1177/0885328219863291 · Cited by 38

Gene therapy for Cystic Fibrosis: recent advances and future prospects

Lomunova, M. A., & Гершович, П. М. (2023) · Acta Naturae · doi:10.32607/actanaturae.11708 · Cited by 39

Inhalable materials and biologics for lung defence and drug delivery

Zhang, S., Edwards, D. A., Langer, R., & Cheng, K. (2025) · Nature Reviews Materials · doi:10.1038/s41578-025-00841-y · Cited by 46

Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination

Glass, J. J., Kent, S. J., & Rose, R. D. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1141054 · Cited by 34

Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis

Villate-Beitia, I., Sesma, J. Z., Puras, G., & Pedraz, J. L. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1298122 · Cited by 38

Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?

Avcı, E., Sarvari, P., Savai, R., Seeger, W., & Pullamsetti, S. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010546 · Cited by 33

Nanoparticle diffusion in spontaneously expectorated sputum as a biophysical tool to probe disease severity in COPD

Chisholm, J., Shenoy, S., Shade, J. K., Kim, V., Putcha, N., Carson, K. A., Wise, R. A., Hansel, N. N., Hanes, J. S., Suk, J. S., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00088-2019 · Cited by 33

Spray drying: Inhalable powders for pulmonary gene therapy

Munir, M., Jena, L., Kett, V. L., Dunne, N., & McCarthy, H. O. (2021) · Biomaterials Advances · doi:10.1016/j.msec.2021.112601 · Cited by 32

Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases

Carneiro, S. P., Greco, A., Chiesa, E., Genta, I., & Merkel, O. M. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2185220 · Cited by 33

Functional Nanocarrier for Drug and Gene Delivery Via Local Administration in Mucosal Tissues

Wang, L., Zhou, Y., Wu, M., Wu, M., Li, X., Gong, X., Chang, J. K., & Zhang, X. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0143 · Cited by 31

Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy

Neill, B., Romero, A. R., & Fenton, O. S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00721 · Cited by 31

Magnetic wire active microrheology of human respiratory mucus

Radiom, M., Hénault, R., Mani, S., Grein-Iankovski, A., Norel, X., & Berret, J. (2021) · Soft Matter · doi:10.1039/d1sm00512j · Cited by 29

Poly (β amino esters) copolymers: Novel potential vectors for delivery of genes and related therapeutics

Iqbal, S., & Zhao, Z. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121289 · Cited by 29

Engineering of pulmonary surfactant corona on inhaled nanoparticles to operate in the lung system

Falahati, M., Hasan, A., Zeinabad, H. A., Serpooshan, V., von der Thüsen, J. H., & ten Hagen, T. L. M. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101998 · Cited by 29

A Two‐Pronged Pulmonary Gene Delivery Strategy: A Surface‐Modified Fullerene Nanoparticle and a Hypotonic Vehicle

Chen, D., Liu, S., Chen, D., Liu, J., Wu, J., Wang, H., Su, Y., Kwak, G., Zuo, X., Rao, D., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101732 · Cited by 28

Poly (beta‐amino ester) as an in vivo nanocarrier for therapeutic nucleic acids

Nezhad, M. S. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28269 · Cited by 28

Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier

Suk, J. S., Kim, A. J., Trehan, K., Schneider, C. S., Cebotaru, L., Woodward, O. M., Boylan, N. J., Boyle, M., Lai, S. K., Guggino, W. B., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.01.007 · Cited by 193

Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier

Kim, N., Kwak, G., Rodriguez, J., Livraghi-Butrico, A., Zuo, X., Simon, V., Han, E., Shenoy, S., Pandey, N., Mazur, M., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215185 · Cited by 22

A Two‐Pronged Pulmonary Gene Delivery Strategy: A Surface‐Modified Fullerene Nanoparticle and a Hypotonic Vehicle

Chen, D., Liu, S., Chen, D., Liu, J., Wu, J., Wang, H., Su, Y., Kwak, G., Zuo, X., Rao, D., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101732 · Cited by 28

Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier

Gioia, S. D., Trapani, A., Castellani, S., Carbone, A., Belgiovine, G., Craparo, E. F., Puglisi, G., Cavallaro, G., Trapani, G., & Conese, M. (2015) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2015.07.003 · Cited by 53

Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-l-lysine

Boylan, N. J., Kim, A. J., Suk, J. S., Adstamongkonkul, P., Simons, B. W., Lai, S. K., Cooper, M. J., & Hanes, J. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.080 · Cited by 54